Home
Scholarly Works
Longitudinal humoral response in MS patients...
Conference

Longitudinal humoral response in MS patients treated with Cladribine tablets after receiving the second and third doses of SARS-CoV-2 mRNA vaccine

Authors

Brill L; Rechtman A; Zveik O; Shifrin A; Rozenberg A; Afanasiev S; Haham N; Levin N; Vaknin-Dembinsky A

Volume

28

Pagination

pp. 651-652

Publisher

SAGE PUBLICATIONS LTD

Publication Date

October 1, 2022

Name of conference

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis

Conference place

NETHERLANDS, Amsterdam

Conference start date

October 26, 2022

Conference end date

October 28, 2022

Conference proceedings

MULTIPLE SCLEROSIS JOURNAL

Issue

3_SUPPL

ISSN

1352-4585

Contact the Experts team